During the past decade, Carl - Thiem - Klinkum Cottbus conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carl - Thiem - Klinkum Cottbus" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 3 trials sponsored and "Charite University, Berlin, Germany" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carl - Thiem - Klinkum Cottbus" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "University of Leipzig" with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "BARMER GEK Germany" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Carl - Thiem - Klinkum Cottbus" are "Lymphoma" (6 trials), "Neuroblastoma" (3 trials), "Chronic Heart Failure" (2 trials), "Acute Respiratory Failure" (1 trials) and "Anaplastic Astrocytoma WHO Grade III" (1 trials). Many other conditions were trialed in "Carl - Thiem - Klinkum Cottbus" in a lesser frequency.

Most popular intervention types in "Carl - Thiem - Klinkum Cottbus" are "Drug" (27 trials), "Radiation" (11 trials), "Biological" (10 trials), "Procedure" (9 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "doxorubicin hydrochloride" (9 trials), "radiation therapy" (9 trials), "vincristine sulfate" (9 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Carl - Thiem - Klinkum Cottbus" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Carl - Thiem - Klinkum Cottbus". undefined are not yet recruiting, 8 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Carl - Thiem - Klinkum Cottbus, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Carl - Thiem - Klinkum Cottbus, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

Carl - Thiem - Klinkum Cottbus has several departments that took part in Clinical trials: "Carl-Thiem-Klinikum, Kinderklinik, Abt. Hämatologie/Onkologie" - 2 trials